Canada markets open in 1 hour 18 minutes

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.5700-0.0500 (-1.91%)
At close: 04:00PM EDT
2.5803 +0.01 (+0.40%)
Pre-Market: 08:00AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 314.47M
Enterprise Value 164.40M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.03
Price/Book (mrq)11.24
Enterprise Value/Revenue 4.29
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.59
52-Week Change 3-65.46%
S&P500 52-Week Change 327.84%
52 Week High 39.6200
52 Week Low 30.8010
50-Day Moving Average 33.6898
200-Day Moving Average 32.5939

Share Statistics

Avg Vol (3 month) 32.16M
Avg Vol (10 day) 32.29M
Shares Outstanding 5122.36M
Implied Shares Outstanding 6122.36M
Float 875.26M
% Held by Insiders 11.36%
% Held by Institutions 199.51%
Shares Short (Apr 30, 2024) 410.92M
Short Ratio (Apr 30, 2024) 46.59
Short % of Float (Apr 30, 2024) 411.74%
Short % of Shares Outstanding (Apr 30, 2024) 48.92%
Shares Short (prior month Mar 28, 2024) 410.13M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-227.16%

Management Effectiveness

Return on Assets (ttm)-33.91%
Return on Equity (ttm)-292.19%

Income Statement

Revenue (ttm)38.3M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)18.50%
Gross Profit (ttm)N/A
EBITDA -132.54M
Net Income Avi to Common (ttm)-134.81M
Diluted EPS (ttm)-1.1200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)183.15M
Total Cash Per Share (mrq)1.5
Total Debt (mrq)33.72M
Total Debt/Equity (mrq)120.47%
Current Ratio (mrq)3.51
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-172.53M
Levered Free Cash Flow (ttm)-99.14M